SPOTLIGHT: Recall cuts Medtronic profits, but not much

Medtronic's quarterly earnings weren't hit as hard as expected by the recall of its Fidelis defibrillator lead; the device maker posted $666 million in earnings on $3.12 billion in revenues. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.